-
Press Release
2020/07/13
Abnova’s COVID-19 Human IgM IgG Rapid Test Gains CE-IVD Approval and Sales Order from Abroad
-
Press Release
2020/07/01
Abnova’s EUA Approved COVID-19 Viral Extraction Kit Captured More Significant Orders as Market Demand Outpaced Supply
-
Press Release
2020/06/17
Abnova & Assurance Scientific Received FDA Clinical Laboratory EUA Approval for its COVID-19 Viral Extraction Kit
-
Press Release
2020/06/11
Abnova Accelerates its COVID-19 Therapeutic Antibody Humanization with Leadgene Biomedical
-
Press Release
2020/05/12
Abnova Moves its Self-Amplifying mRNA Vaccine Testing to Larger Animals Targeting COVID-19 This Month
-
Press Release
2020/04/17
Abnova and AsiaGen Taiwan Set First Phase COVID-19 IgM IgG Rapid Test Production Target to 25,000 Tests Per Month
-
Press Release
2020/03/16
Abnova and Labospace Accelerate COVID-19 Serum Antibody Rapid Test Clinical Study in Italy for CE-IVD Certification
-
Press Release
2020/03/06
Abnova Setup Serum IgM/IgG ELISA Test for COVID-19 Coronavirus
-
Press Release
2020/02/20
Abnova Team Up with Chung Yuan Christian University using COVID-19 VLP for Therapeutic Antibody Validation
-
Press Release
2020/02/13
Abnova’s Cell-Surface Vimentin (CSV) Therapeutic Monoclonal Antibody Targeting Wuhan 2019-nCoV Coronavirus